Navigation Links
Looking Older Than You Are May Have Little to Do With Wrinkles
Date:7/22/2009

What's the biggest aging factor and how is it addressed? International Sculptra trainer Dr. Rebecca Fitzgerald, known among her medical colleagues as the "Sculptra guru" here in the U.S., presented her findings on Facial Volume Restoration to an internationally represented group of physicians at this year's 4 day SDEF Cosmetic Dermatology Seminar held in Santa Monica, Ca.

Los Angeles, Ca (PRWEB) July 22, 2009 -- Dr. Rebecca Fitzgerald, known among her medical colleagues as the Sculptra "guru" here in the U.S., presented her findings on Facial Volume Restoration to an internationally represented group of physicians at this year's 4 day SDEF Cosmetic Dermatology Seminar held in Santa Monica, Ca.

Dr. Fitzgerald's research and intense focus on injectable agents for creating - and recreating - facial balance and harmony was received with a hearty round of applause and the "beehive" of physicians surrounding her after the presentation asking questions and advice.

She is a primary international training physician and consultant for Dermik Laboratories, makers of Sculptra, and travels extensively in both the U.S. and abroad for the training of qualified surgeons and dermatologists, as well as presenting at numerous seminars and major medical conferences around the world. Dr. Fitzgerald has been featured on several news programs, including Entertainment Tonight. Sculptra. already used cosmetically in Europe for over 10 years, is poised to be the first approved collagen-stimulating injectable in the US.

Dr. Fitzgerald began her experience with Sculptra a number of years ago while working in the Dermatology Department at Kaiser Permanente in Los Angeles. She developed and oversaw the clinic for HIV lipoatrophy, the condition for which Sculptra was first used in the U.S. After man hundreds of patient visits and remarkable results, Dr. Fitzgerald's research became focused on the cosmetic applications for restoring facial volume deficiencies caused by age and genetic structure. Sculptra, as a bio-stimulatory agent, acts over time to create self-production of new collagen in the skin. It is the only recognized product to have this effect.

In her presentation Dr. Fitzgerald noted that identifying early facial imbalance is key to both correction and prevention. The worse it gets, the worse it gets, is how she phrased the dilemma. "By correcting early with smaller volume treatments, you can slow the aging process and allay the need for major procedures later on. It really is a 'worse begets worse' scenario because once the skin begins to lose its support system through natural collagen breakdown, a cascade effect occurs."

With dozens of her patient photos and two close-up live feed demonstrations, Dr. Fitzgerald held rapt attention of the conference attendees and her fellow panel members. "Correct placement is critical," she explained. "You can find the breaks in the facial plane with certain manipulations of the skin and a really intense visual examination of the highlights and shadows that skin contours create. The balance of convex and concave contours makes the difference between looking older - or looking younger."

Dr. Fitzgerald is a close medical colleague of Europe's Dr. Danny Vleggar, considered to be "the" name in the Sculptra revolution in Europe where the product has been used for cosmetic purposes for 10 years. Both experts are often linked in research, training and video training modules for Dermik.

Dermik is the dermatology arm of Sanofi Aventis, one of Europe's largest pharmaceutical companies. Full cosmetic application approval from the FDA is expected in the U.S within months.

Dr. Rebecca Fitzgerald is a Board Certified Dermatologist and Internist with a private practice located in the Larchmont area of Los Angeles. She is on the clinical faculty at UCLA Dermatology Department and a member of many Laser and Dermatology societies. Dr. Fitzgerald maintains an educational practice website RebeccaFitzgeraldMD.com. Contact phone (323) 464-8046.

###

Read the full story at http://www.prweb.com/releases/sculptra/los_angeles/prweb2663214.htm.


'/>"/>
Source: PRWeb
Copyright©2009 Vocus, Inc.
All rights reserved  

Related biology technology :

1. Looking at AMD Through Patients' Eyes: Viscira Virtual Exhibit Educates Physicians by Personalizing Serious Eye Disease
2. Consumers Looking to Sustainable Food Production to Feed Global Population
3. Wyeth Announces Stockholder Approval of Pfizer Merger at 2009 Annual Meeting
4. TransTech Services Partners, Inc. Shareholders Approve Plan of Liquidation; Company To Distribute Amounts in Trust
5. Cornerstone Therapeutics Inc. Announces Record Date and Meeting Date for Special Meeting of Stockholders for Vote with Respect to Charter Amendments
6. Tianyin Pharmaceutical Co., Inc. Announces Cash Dividend to Common Stockholders
7. CEL-SCI Corporation Releases Letter to Shareholders
8. Wyeth Announces Holder Right to Surrender Convertible Debentures
9. Modigene Shareholders Approve Company Name Change and Other Proposals at Annual Meeting
10. Dragon Pharma Announces June 21, 2009 for 2009 Annual Shareholders Meeting
11. The Concerned Shareholders of Biovail Say Biovail Has Misled Shareholders
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Looking Older Than You Are May Have Little to Do With Wrinkles
(Date:6/27/2016)... Raleigh, NC (PRWEB) , ... June 27, 2016 ... ... have just published their findings on what they believe could be a new ... summary of the new research. Click here to read it now. ...
(Date:6/27/2016)... , June 27, 2016  Liquid Biotech ... announced the funding of a Sponsored Research Agreement ... circulating tumor cells (CTCs) from cancer patients.  The ... in CTC levels correlate with clinical outcomes in ... These data will then be employed to support ...
(Date:6/24/2016)... ... 24, 2016 , ... While the majority of commercial spectrophotometers and fluorometers use ... 6000i models are higher end machines that use the more unconventional z-dimension of 20mm. ... from the bottom of the cuvette holder. , FireflySci has developed several Agilent ...
(Date:6/23/2016)... 2016   Boston Biomedical , an industry ... to target cancer stemness pathways, announced that its ... Drug Designation from the U.S. Food and Drug ... including gastroesophageal junction (GEJ) cancer. Napabucasin is an ... cancer stemness pathways by targeting STAT3, and is ...
Breaking Biology Technology:
(Date:4/19/2016)... , UAE, April 20, 2016 ... be implemented as a compact web-based "all-in-one" system solution ... the biometric fingerprint reader or the door interface with ... of modern access control systems. The minimal dimensions of ... ID readers into the building installations offer considerable freedom ...
(Date:4/13/2016)... 13, 2016  IMPOWER physicians supporting Medicaid patients in ... new clinical standard in telehealth thanks to a new ... higi platform, IMPOWER patients can routinely track key health ... mass index, and, when they opt in, share them ... to a local retail location at no cost. By ...
(Date:3/23/2016)... Massachusetts , March 23, 2016 /PRNewswire/ ... im Interesse erhöhter Sicherheit Gesichts- und Stimmerkennung ... Xura, Inc. (NASDAQ: MESG ), ... bekannt, dass das Unternehmen mit SpeechPro zusammenarbeitet, ... aus der Finanzdienstleistungsbranche, wird die Möglichkeit angeboten, ...
Breaking Biology News(10 mins):